Alopecia areata after COVID-19 vaccination

Area of Science:

• Dermatology
• Immunology
• Vaccinology

Background:

• COVID-19 vaccines (SARS-CoV-2) are widely authorized globally.
• Cutaneous manifestations following SARS-CoV-2 vaccination have been documented.
• Alopecia areata is a prevalent autoimmune condition causing non-scarring hair loss.

Observation:

• A patient experienced rapid-onset alopecia areata after their second COVID-19 vaccine dose.
• This is the first reported case of alopecia areata following COVID-19 vaccination in the literature.
• A review of alopecia areata cases after other vaccinations was conducted.

Findings:

• Alopecia areata has not previously been described as a cutaneous adverse effect of anti-SARS-CoV-2 vaccination.
• The temporal association suggests a potential link between COVID-19 vaccination and alopecia areata onset.
• The study includes a literature review of alopecia areata post-vaccination.

Implications:

• The clinical significance of vaccine-associated alopecia areata remains unknown.
• Further research is needed to understand the relationship between alopecia areata and COVID-19 vaccination.
• Immune-mediated reactions like alopecia areata may offer insights into vaccine-induced immune protection against SARS-CoV-2.